AlveoliX AG
Best In-Vitro Biotechnology Company - Bern
Scroll to keep reading
Best In-Vitro Biotechnology Company - Bern
AlveoliX aims at changing classical drug development by providing advanced
in-vitro models that reproduce the in-vivo environment in an unprecedented
manner. By doing so, we want to make organs-on-chip technology the new
standard for preclinical decision-making.
Our easy-to-use 3D culture models provide the essential know-how and inspiration to
design better and safer drugs. At the same time, they allow researchers to
investigate and understand critical cellular pathways more accurately by including
the breathing function to simulate the micro-environment of the lung, allowing to
recreate healthy, diseased, and personalized models to test molecule safety (drugs,
pollutants, cosmetics, etc.) and drug efficacy as an alternative to animal models.
www.alveolix.com
https://www.linkedin.com/company/alveolix
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
